• 10 March, 2014
  • The ISSCR 12th Annual Meeting will take place June 18-21, 2014 at the Vancouver Convention Centre in Vancouver, British Columbia, Canada. The meeting will bring together approximately 4,000 stem cell scientists, bioethicists, clinicians and industry professionals from over 50 countries to present and discuss the latest research and technologies within the field.
    Full story
  • 6 March, 2014
  • Induced pluripotent stem cells (iPS cells) have been hailed as a future cell therapy, but they are playing an equally important role in research, revolutionizing the way scientists study human disease. By cultivating human stem cell lines in a dish, scientists are better able to understand diseases, including those with unique genetic markers.
    Full story
  • Two Papers Open a New Window into Pluripotency

    1/29/2014 6:00:00 AM

    The ISSCR is pleased to help spread the news about two papers published online today in Nature that describe the induction of pluripotency in cells from a newborn mouse without the use of extrinsic transcription factors, chemical manipulation or nuclear transfer.
    Full story
  • 14 January, 2014
  • The ISSCR announces recipients of its 2014 awards, which will be presented at the 12th Annual Meeting in Vancouver, taking place June 18-21, 2014.
    Full story
  • Workshop, "Stem Cell Therapies: Opportunities for Assuring the Quality and Safety of Unregulated Clinical Offerings"

  • 7 November, 2013
  • The ISSCR, the Institute of Medicine and the National Academy of Sciences, is hosting a Washington, DC-based workshop and live webcast examining the practice and consequences of unproven stem cell treatments on November 18, 2013 from 8:30 a.m.-5:30 p.m. EDT
    Full story
  • ISSCR Statement of Delivery of Unproven Autologous Cell-based Interventions to Patients

  • 12 September, 2013
  • The International Society for Stem Cell Research (ISSCR) urges medical licensing bodies, legal authorities, patient advocacy organizations, physicians, and others to exercise their influence to discourage commercial provision of unproven autologous cell-based interventions outside of clinical trials.
    Full story
  • ISSCR Celebrates Inaugural Issue of its Open Access Journal, Stem Cell Reports

  • 4 June, 2013
  • 6/4/2013 5:00:00 AM

    The International Society for Stem Cell Research (ISSCR) is excited to announce the inaugural issue of Stem Cell Reports, the society’s new open-access journal, published today. Stem Cell Reports, published for the ISSCR by Cell Press, presents high-quality, peer-reviewed research presenting conceptual or practical advances across the breadth of stem cell research and its applications to medicine, with a focus on shorter, single-point articles.
    Full story
  • ISSCR Emphasizes Importance of Regulatory Oversight for Stem Cell Products for Clinical Use

  • 22 April, 2013
  • The ISSCR urges Italian lawmakers to heed concerns of scientists around the world about the premature practice of unproven stem cell treatments and to recognize the importance of regulatory oversight and patient protection when developing new stem cell medicines.
    Full story
  • ISSCR Voices Concern as Italian Government Authorizes Unproven Stem Cell Therapy

  • 9 April, 2013
  • The International Society for Stem Cell Research (ISSCR) voices concern as the Italian government authorizes an unproven stem cell therapy for use in patients.
    Full story
  • ISSCR President, Board Member, and 11th Annual Meeting Keynote Speaker Among Winners of Breakthrough Prize

  • 20 February, 2013
  • ISSCR President, Shinya Yamanaka, Board of Directors member Hans Clevers and the ISSCR 2013 Annual Meeting Keynote Speaker Eric Lander, were three of 11 distinguished recipients of the inaugural Breakthrough Prize in Life Sciences, announced today
    Full story
  • ISSCR Statement on U.S. Supreme Court decision to deny certiorari in case of Sherley v. Sebelius

  • 7 January, 2013
  • The International Society for Stem Cell Research (ISSCR) welcomes the decision of the US Supreme Court to deny certiorari in the case of Sherley v Sebelius, which had challenged federal funding of human embryonic stem cell research.
    Full story
  • ISSCR to Launch Open Access Journal, Stem Cell Reports

  • 24 October, 2012
  • The International Society for Stem Cell Research (ISSCR) announces the launch of Stem Cell Reports, its new online, open-access journal. With a focus on shorter, single-point articles, Stem Cell Reports will publish high-quality, peer-reviewed research presenting conceptual or practical advances across the breadth of stem cell research and its applications to medicine.
    Full story
  • ISSCR Reaffirms Support for All Forms of Stem Cell Research

  • 11 October, 2012
  • The ISSCR further congratulates Drs. Shinya Yamanaka and John Gurdon for their scientific achievements recognized by this year's Nobel Prize and reaffirms support for all forms of stem cell research.
    Full story
  • ISSCR Statement on Court Decision Upholding a Dismissal of Challenges to Federal Funding of Human Embryonic Stem Cell Research

  • 30 August, 2012
  • The International Society for Stem Cell Research (ISSCR) welcomes the finding of the U.S. Court of Appeals for the District of Columbia upholding an earlier dismissal of Sherley v Sebelius, a court case that had challenged federal funding of human embryonic stem cell research.
    Full story
  • The ISSCR Selects Yokohama, Japan, for its 10th Annual Meeting; First in Asia

  • 10 May, 2012
  • 5/10/2012 5:00:00 AM

    The ISSCR will hold its 10th annual meeting June 13-16, 2012, in Yokohama, Japan, at the PACIFICO Yokohama.
    Full story
  • ISSCR Emphasizes Rigorous Oversight for Application of Stem Cell-Based Treatments

  • 12 April, 2012
  • The ISSCR is concerned that some stem cell treatments are being prematurely offered to patients without safeguards in place to ensure safety and efficacy.
    Full story
  • ISSCR Honors Stem Cell Research Pioneer with Prestigious McEwen Award for Innovation

  • 23 February, 2012
  • The ISSCR is pleased to announce the winner of the 2012 McEwen Award for Innovation, a coveted prize in the field of stem cell research and regenerative medicine. The 2012 recipient is Rudolf Jaenisch, MD, Founding Member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of Technology
    Full story
  • ISSCR Statement on Recent Somatic Cell Nuclear Transfer (SCNT) Breakthrough: An Important Step Forward

  • 5 October, 2011
  • The International Society for Stem Cell Research (ISSCR) welcomes today’s announcement of an advance in stem cell science and reprogramming through somatic cell nuclear transfer or SCNT.
    Full story
  • ISSCR Statement on U.S. Court Decision to Dismiss Challenges to Federal Funding of Human Embryonic Stem Cell Research

  • 27 July, 2011
  • 7/27/2011 5:00:00 AM

    The ISSCR applauds the decision announced today by the U.S. District Court for the District of Columbia in the case of Sherley v. Sebelius, dismissing challenges to the U.S. National Institutes of Health’s (NIH’s) funding of human embryonic stem cell research.
    Full story
    View All ISSCR News